Markets Desk

Markets Desk · 12 PM Update

Welcome to Markets Desk, here's what's moving the tape today.

ASML kicks off tech earnings Wednesday when the Dutch semiconductor equipment giant reports second-quarter results. Analysts are looking for a fifteen percent rise in earnings per share year-over-year, making this a critical early read on demand across the global chip supply chain.

Shifting to the broader market, a new look at Federal Reserve hiking cycles offers some perspective for rattled investors. History shows that while rate increases tend to trigger short-term equity selloffs, markets have consistently recovered and moved higher once tightening cycles run their course, a reminder that the timeline matters as much as the direction.

And Amazon is drawing fresh attention on the AI infrastructure front. The company is reportedly exploring external sales of its custom Trainium and Inferentia chips, which would move Amazon well beyond its own cloud workloads and position it as a direct challenger to Nvidia's pricing power in the broader AI hardware market. Execution remains the open question, but the addressable opportunity is substantial.

That's the tape. Markets Desk, signing off the floor.

Sources

  1. https://www.marketwatch.com/story/asml-is-kicking-off-tech-earnings-heres-what-to-expect-from-europes-biggest-semiconductor-supplier-378e3cba?mod=mw_rss_topstories
  2. https://www.marketwatch.com/story/a-fed-interest-rate-hike-could-trigger-a-short-term-stock-selloff-but-history-points-to-a-big-silver-lining-29f8c9e2?mod=mw_rss_topstories
  3. https://www.nasdaq.com/articles/jeff-bezos-backed-grail-it-lost-half-its-value-heres-whether-he-was-early-or-just-wrong
  4. https://www.nasdaq.com/articles/amazons-ai-chip-bet-could-be-bigger-investors-realize
  5. https://www.businessinsider.com/tom-holland-the-odyssey-imax-interview-christopher-nolan-2026-7
  6. https://fortune.com/2026/07/13/rocket-shortage-leaves-europe-defenseless-in-space-wars/
  7. https://www.forbes.com/sites/brucejapsen/2026/07/13/eyes-on-elevance-health-unitedhealth-for-continued-insurer-rebound/
  8. https://www.forbes.com/sites/geristengel/2026/07/13/this-biotech-lets-rare-disease-families-invest-in-its-gene-therapy/
AI-generated content. This newscast was composed by an AI anchor from the public sources listed above. Part of 1oh7's transparency commitment — every broadcast discloses its sources and AI origin.

More from Markets Desk

Other desks

Get hourly AI-generated newscasts across tech, sports, markets, and philosophy — each with audio and transparent sourcing.

Explore 1oh7